Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Sabine Vogler, Maximilian Salcher-Konrad & Katharina Habimana. (2023) Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?. Expert Review of Pharmacoeconomics & Outcomes Research 23:8, pages 867-878.
Read now
Read now
Daniel Resende Faleiros, Everton Nunes da Silva, Andreia C Santos, Brian B. Godman, Ramon Goncalves Pereira & Augusto A Guerra Junior. (2022) Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions. Expert Review of Pharmacoeconomics & Outcomes Research 22:6, pages 927-939.
Read now
Read now
Daniel Resende Faleiros, Juliana Alvares-Teodoro, Everton Nunes da Silva, Brian B. Godman, Ramon Gonçalves Pereira, Eli Iola Gurgel Andrade, Francisco A. de Assis Acurcio & Augusto A. Guerra Júnior. (2022) Budget impact analysis of medicines: estimated values versus real-world evidence and the implications. Expert Review of Pharmacoeconomics & Outcomes Research 22:2, pages 271-281.
Read now
Read now
Brian Godman, Mainul Haque, Santosh Kumar, Salequl Islam, Jaykaran Charan, Farhana Akter, Amanj Kurdi, Eleonora Allocati, Muhammed Abu Bakar, Sagir Abdur Rahim, Nusrat Sultana, Farzana Deeba, M. A. Halim Khan, A. B. M Muksudul Alam, Iffat Jahan, Zubair Mahmood Kamal, Humaira Hasin, Munzur-E-Murshid, Shamsun Nahar, Monami Haque, Siddhartha Dutta, Jha Pallavi Abhayanand, Rimple Jeet Kaur, Jitendra Acharya, Takuma Sugahara, Hye-Young Kwon, SeungJin Bae, Karen Koh Pek Khuan, Tanveer Ahmed Khan, Shahzad Hussain, Zikria Saleem, Alice Pisana, Janney Wale & Mihajlo Jakovljevic. (2021) Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future. Current Medical Research and Opinion 37:9, pages 1529-1545.
Read now
Read now
Eleonora Allocati & Brian Godman. (2020) Key patient related factors in the management of inflammatory bowel disease. Journal of Medical Economics 23:12, pages 1606-1609.
Read now
Read now
Patricia Vella Bonanno, Anna Bucsics, Steven Simoens, Antony P Martin, Wija Oortwijn, Jolanta Gulbinovič, Celia Rothe, Angela Timoney, Alessandra Ferrario, Mohamed Gad, Ahmed Salem, Iris Hoxha, Robert Sauermann, Maria Kamusheva, Maria Dimitrova, Guenka Petrova, Ott Laius, Gisbert Selke, Vasilios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Arianit Jakupi, Tomasz Bochenek, Magdalene Wladysiuk, Claudia Furtado, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Jurij Fürst, Dominik Tomek, Merce Obach Cortadellas, Corrine Zara, Alan Haycox, Stephen Campbell & Brian Godman. (2019) Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA. Expert Review of Pharmacoeconomics & Outcomes Research 19:3, pages 251-261.
Read now
Read now
André Soares Santos, Augusto Afonso Guerra-Junior, Brian Godman, Alec Morton & Cristina Mariano Ruas. (2018) Cost-effectiveness thresholds: methods for setting and examples from around the world. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 277-288.
Read now
Read now
Moliehi Matlala, Andries GS Gous, Brian Godman & Johanna C Meyer. (2017) Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Review of Clinical Pharmacology 10:11, pages 1273-1280.
Read now
Read now
Tomasz Bochenek, Ewa Kocot, Marcin Rodzinka, Brian Godman, Katarzyna Maciejewska, Susan Kamal & Andrzej Pilc. (2017) The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland. Expert Review of Pharmacoeconomics & Outcomes Research 17:4, pages 385-400.
Read now
Read now
Articles from other publishers (23)
Hyunjung Woo, Gyeongseon Shin, Donghwan Lee, Hye-Young Kwon & SeungJin Bae. (2023) Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries. BioDrugs.
Crossref
Crossref
Eleonora Allocati, Brian Godman, Marco Gobbi, Silvio Garattini & Rita Banzi. (2022) Switching Among Biosimilars: A Review of Clinical Evidence. Frontiers in Pharmacology 13.
Crossref
Crossref
Brian Godman, Magdalene Wladysiuk, Stuart McTaggart, Amanj Kurdi, Eleonora Allocati, Mihajlo Jakovljevic, Francis Kalemeera, Iris Hoxha, Anna Nachtnebel, Robert Sauermann, Manfred Hinteregger, Vanda Marković-Peković, Biljana Tubic, Guenka Petrova, Konstantin Tachkov, Juraj Slabý, Radka Nejezchlebova, Iva Selke Krulichová, Ott Laius, Gisbert Selke, Irene Langner, András Harsanyi, András Inotai, Arianit Jakupi, Svens Henkuzens, Kristina Garuolienė, Jolanta Gulbinovič, Patricia Vella Bonanno, Jakub Rutkowski, Skule Ingeberg, Øyvind Melien, Ileana Mardare, Jurij Fürst, Sean MacBride-Stewart, Carol Holmes, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Mikael Hoffmann, Vasileios Kourafalos, Alice Pisana, Rita Banzi, Stephen Campbell & Bjorn Wettermark. (2021) Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications. BioMed Research International 2021, pages 1-16.
Crossref
Crossref
Brian Godman, Joseph Fadare, Hye-Young Kwon, Carolina Zampirolli Dias, Amanj Kurdi, Isabella Piassi Dias Godói, Dan Kibuule, Iris Hoxha, Sylvia Opanga, Zikria Saleem, Tomasz Bochenek, Vanda Marković-Peković, Ileana Mardare, Aubrey C Kalungia, Stephen Campbell, Eleonora Allocati, Alice Pisana, Antony P Martin & Johanna C Meyer. (2021) Evidence-based public policy making for medicines across countries: findings and implications for the future. Journal of Comparative Effectiveness Research 10:12, pages 1019-1052.
Crossref
Crossref
C.R.H. Hedin, E. Sonkoly, M. Eberhardson & M. Ståhle. (2021) Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach. Journal of Internal Medicine 290:2, pages 257-278.
Crossref
Crossref
Minyoung Jang, Steven Simoens & Taeksang Kwon. (2020) Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets. BioDrugs 35:1, pages 89-101.
Crossref
Crossref
Moliehi Matlala, Andries G. S. Gous, Johanna C. Meyer & Brian Godman. (2020) Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province. Frontiers in Pharmacology 11.
Crossref
Crossref
Daniel Aletaha. (2020) Precision medicine and management of rheumatoid arthritis. Journal of Autoimmunity 110, pages 102405.
Crossref
Crossref
Mohamed Gad, Ahmed Salem, Wija Oortwijn, Ruaraidh Hill & Brian Godman. (2020) Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions. Frontiers in Pharmacology 11.
Crossref
Crossref
Caridad Pontes, Corinne Zara, Josep Torrent-Farnell, Merce Obach, Cristina Nadal, Patricia Vella-Bonanno, Michael Ermisch, Steven Simoens, Renata Curi Hauegen, Jolanta Gulbinovic, Angela Timoney, Antony P. Martin, Tanja Mueller, Anna Nachtnebel, Stephen Campbell, Gisbert Selke, Tomasz Bochenek, Celia C. Rothe, Ileana Mardare, Marion Bennie, Jurij Fürst, Rickard E. Malmstrom & Brian Godman. (2019) Time to Review Authorisation and Funding for New Cancer Medicines in Europe? Inferences from the Case of Olaratumab. Applied Health Economics and Health Policy 18:1, pages 5-16.
Crossref
Crossref
André Soares Santos, Augusto Afonso Guerra-Junior, Kenya Valéria Micaela de Souza Noronha, Mônica Viegas Andrade & Cristina Mariano Ruas. (2019) The Price of Substitute Technologies. Value in Health Regional Issues 20, pages 154-158.
Crossref
Crossref
Seung-Mi Lee, Jae-Ho Jung, David Suh, Yu-Seon Jung, Seung-Lai Yoo, Dong-Won Kim, Ji-An Kim & Dong-Churl Suh. (2019) Budget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries. BioDrugs 33:4, pages 423-436.
Crossref
Crossref
Daniel C. Baumgart, Laurent Misery, Sue Naeyaert & Peter C. Taylor. (2019) Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?. Frontiers in Pharmacology 10.
Crossref
Crossref
Brian Godman, Anna Bucsics, Patricia Vella Bonanno, Wija Oortwijn, Celia C. Rothe, Alessandra Ferrario, Simone Bosselli, Andrew Hill, Antony P. Martin, Steven Simoens, Amanj Kurdi, Mohamed Gad, Jolanta Gulbinovič, Angela Timoney, Tomasz Bochenek, Ahmed Salem, Iris Hoxha, Robert Sauermann, Amos Massele, Augusto Alfonso GuerraJr.Jr., Guenka Petrova, Zornitsa Mitkova, Gnosia Achniotou, Ott Laius, Catherine Sermet, Gisbert Selke, Vasileios Kourafalos, John Yfantopoulos, Einar Magnusson, Roberta Joppi, Margaret Oluka, Hye-Young Kwon, Arianit Jakupi, Francis Kalemeera, Joseph O. Fadare, Oyvind Melien, Maciej Pomorski, Magdalene Wladysiuk, Vanda Marković-Peković, Ileana Mardare, Dmitry Meshkov, Tanja Novakovic, Jurij Fürst, Dominik Tomek, Corrine Zara, Eduardo Diogene, Johanna C. Meyer, Rickard Malmström, Björn Wettermark, Zinhle Matsebula, Stephen Campbell & Alan Haycox. (2018) Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets. Frontiers in Public Health 6.
Crossref
Crossref
Arianit Jakupi, Brian Godman, Antony Martin, Alan Haycox & Indrit Baholli. (2018) Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications. PharmacoEconomics - Open 2:4, pages 423-432.
Crossref
Crossref
Alessandra Ferrario, Diāna Arāja, Tomasz Bochenek, Tarik Čatić, Dávid Dankó, Maria Dimitrova, Jurij Fürst, Ieva Greičiūtė-Kuprijanov, Iris Hoxha, Arianit Jakupi, Erki Laidmäe, Olga Löblová, Ileana Mardare, Vanda Markovic-Pekovic, Dmitry Meshkov, Tanja Novakovic, Guenka Petrova, Maciej Pomorski, Dominik Tomek, Luka Voncina, Alan Haycox, Panos Kanavos, Patricia Vella Bonanno & Brian Godman. (2017) The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. PharmacoEconomics 35:12, pages 1271-1285.
Crossref
Crossref
Irene Eriksson, Björn Wettermark, Marie Persson, Morgan Edström, Brian Godman, Anna Lindhé, Rickard E. Malmström, Helena Ramström, Mia von Euler & Anna Bergkvist Christensen. (2017) The Early Awareness and Alert System in Sweden: History and Current Status. Frontiers in Pharmacology 8.
Crossref
Crossref
Patricia Vella Bonanno, Michael Ermisch, Brian Godman, Antony P. Martin, Jesper Van Den Bergh, Liudmila Bezmelnitsyna, Anna Bucsics, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Irene Eriksson, Jurij Fürst, Mohamed Gad, Ieva Greičiūtė-Kuprijanov, Martin van der Graaff, Jolanta Gulbinovic, Jan Jones, Roberta Joppi, Marija Kalaba, Ott Laius, Irene Langner, Ileana Mardare, Vanda Markovic-Pekovic, Einar Magnusson, Oyvind Melien, Dmitry O. Meshkov, Guenka I. Petrova, Gisbert Selke, Catherine Sermet, Steven Simoens, Ad Schuurman, Ricardo Ramos, Jorge Rodrigues, Corinne Zara, Eva Zebedin-Brandl & Alan Haycox. (2017) Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation. Frontiers in Pharmacology 8.
Crossref
Crossref
Marina Kostić, Ljiljan Djakovic, Raša Šujić, Brian Godman & Slobodan M. Janković. (2016) Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Applied Health Economics and Health Policy 15:1, pages 85-93.
Crossref
Crossref
Natasha Azzopardi-Muscat, Peter Schroder-Bäck & Helmut Brand. (2016) The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration?. Health Economics, Policy and Law 12:1, pages 43-59.
Crossref
Crossref
Brian Godman, Eduardo Diogene, Jurij Fürst, Kristina Garuoliene, Augusto Guerra, Roberta Joppi, Rickard Malmström, Wija Oortwijn, Gisbert Selke, Angela Timoney & Björn Wettermark. (2018) PP022 New Models Are Needed To Optimize The Management Of New Medicines. International Journal of Technology Assessment in Health Care 33:S1, pages 79-80.
Crossref
Crossref
François Bocquet, Anaïs Loubière, Isabelle Fusier, Anne-Laure Cordonnier & Pascal Paubel. (2016) Competition Between Biosimilars and Patented Biologics: Learning from European and Japanese Experience. PharmacoEconomics 34:11, pages 1173-1186.
Crossref
Crossref
Michael Ermisch, Anna Bucsics, Patricia Vella Bonanno, Francis Arickx, Alexander Bybau, Tomasz Bochenek, Marc van de Casteele, Eduardo Diogene, Jurij Fürst, Kristina Garuolienė, Martin van der Graaff, Jolanta Gulbinovič, Alan Haycox, Jan Jones, Roberta Joppi, Ott Laius, Irene Langner, Antony P. Martin, Vanda Markovic-Pekovic, Laura McCullagh, Einar Magnusson, Ellen Nilsen, Gisbert Selke, Catherine Sermet, Steven Simoens, Robert Sauermann, Ad Schuurman, Ricardo Ramos, Vera Vlahovic-Palcevski, Corinne Zara & Brian Godman. (2016) Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways. Frontiers in Pharmacology 7.
Crossref
Crossref